Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Debt Ratio (2023 - 2025)

Historic Debt Ratio for Xeris Biopharma Holdings (XERS) over the last 3 years, with Q3 2025 value amounting to 0.59.

  • Xeris Biopharma Holdings' Debt Ratio rose 116431.3% to 0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59, marking a year-over-year increase of 116431.3%. This contributed to the annual value of 0.72 for FY2024, which is 1034.94% up from last year.
  • Latest data reveals that Xeris Biopharma Holdings reported Debt Ratio of 0.59 as of Q3 2025, which was up 116431.3% from 0.65 recorded in Q2 2025.
  • In the past 5 years, Xeris Biopharma Holdings' Debt Ratio ranged from a high of 0.73 in Q1 2025 and a low of 0.0 during Q2 2024
  • Over the past 3 years, Xeris Biopharma Holdings' median Debt Ratio value was 0.05 (recorded in 2023), while the average stood at 0.32.
  • As far as peak fluctuations go, Xeris Biopharma Holdings' Debt Ratio crashed by 9749.8% in 2024, and later surged by 5149452.86% in 2025.
  • Xeris Biopharma Holdings' Debt Ratio (Quarter) stood at 0.65 in 2023, then increased by 10.35% to 0.72 in 2024, then decreased by 17.48% to 0.59 in 2025.
  • Its last three reported values are 0.59 in Q3 2025, 0.65 for Q2 2025, and 0.73 during Q1 2025.